As of January 2026, weight-loss drugs like Wegovy and Mounjaro deliver significant initial weight loss, with new approvals expanding dosing options. However, research shows most patients regain lost weight within 20 months after stopping treatment. High costs, side effects, and misconceptions about long-term use contribute to discontinuation. Experts emphasize the need for ongoing lifestyle support and gradual dose reduction to sustain benefits.